Chitosan–nanohydroxyapatite composites: Mechanical, thermal and bio-compatibility studies

Calcium Orthophosphate (CaPO4) Containing Composites for Biomedical Applications: Formulations, Properties, and Applications

The goal of this review is to present a wide range of hybrid formulations and composites containing calcium orthophosphates (abbreviated as CaPO4) that are suitable for use in biomedical applications and currently on the market. The bioactive, biocompatible, and osteoconductive properties of various CaPO4-based formulations make them valuable in the rapidly developing field of biomedical research, both in vitro and in vivo. Due to the brittleness of CaPO4, it is essential to combine the desired osteologic properties of ceramic CaPO4 with those of other compounds to create novel, multifunctional bone graft biomaterials. Consequently, this analysis offers a thorough overview of the hybrid formulations and CaPO4-based composites that are currently known. To do this, a comprehensive search of the literature on the subject was carried out in all significant databases to extract pertinent papers. There have been many formulations found with different material compositions, production methods, structural and bioactive features, and in vitro and in vivo properties. When these formulations contain additional biofunctional ingredients, such as drugs, proteins, enzymes, or antibacterial agents, they offer improved biomedical applications. Moreover, a lot of these formulations allow cell loading and promote the development of smart formulations based on CaPO4. This evaluation also discusses basic problems and scientific difficulties that call for more investigation and advancements. It also indicates perspectives for the future.

Functionalization of PCL-Based Fiber Scaffolds with Different Sources of Calcium and Phosphate and Odontogenic Potential on Human Dental Pulp Cells

This study investigated the incorporation of sources of calcium, phosphate, or both into electrospun scaffolds and evaluated their bioactivity on human dental pulp cells (HDPCs). Additionally, scaffolds incorporated with calcium hydroxide (CH) were characterized for degradation, calcium release, and odontogenic differentiation by HDPCs. Polycaprolactone (PCL) was electrospun with or without 0.5% w/v of calcium hydroxide (PCL + CH), nano-hydroxyapatite (PCL + nHA), or β-glycerophosphate (PCL + βGP). SEM/EDS analysis confirmed fibrillar morphology and particle incorporation. HDPCs were cultured on the scaffolds to assess cell viability, adhesion, spreading, and mineralized matrix formation. PCL + CH was also evaluated for gene expression of odontogenic markers (RT-qPCR). Data were submitted to ANOVA and Student's t-test (α = 5%). Added CH increased fiber diameter and interfibrillar spacing, whereas βGP decreased both. PCL + CH and PCL + nHA improved HDPC viability, adhesion, and proliferation. Mineralization was increased eightfold with PCL + CH. Scaffolds containing CH gradually degraded over six months, with calcium release within the first 140 days. CH incorporation upregulated DSPP and DMP1 expression after 7 and 14 days. In conclusion, CH- and nHA-laden PCL fiber scaffolds were cytocompatible and promoted HDPC adhesion, proliferation, and mineralized matrix deposition. PCL + CH scaffolds exhibit a slow degradation profile, providing sustained calcium release and stimulating HDPCs to upregulate odontogenesis marker genes.

Cytocompatibility and bioactivity of calcium hydroxide-containing nanofiber scaffolds loaded with fibronectin for dentin tissue engineering

OBJECTIVES

The aim of this study was to characterize polycaprolactone-based nanofiber scaffolds (PCL) incorporated with calcium hydroxide (CH) and evaluate their bioactivity on human dental pulp cells (HDPCs) when loaded with fibronectin (FN).

MATERIALS AND METHODS

CH (0.1%; 0.2%; 0.4% w/v; or 0%) was incorporated into PCL (10% w/v) scaffolds prepared by electrospinning. Morphology and composition were characterized using SEM/EDS. HDPCs were seeded on the scaffolds and evaluated for viability (alamarBlue; Live/Dead), and adhesion/spreading (F-actin). Next, scaffolds containing 0.4% CH were loaded with FN (20 µg/mL). HDPCs were evaluated for viability, adhesion/spreading, migration (Trans-well), gene expression (RT-qPCR), alkaline phosphatase activity (ALP), and mineralization nodules (Alizarin Red). Data were submitted to ANOVA and post-hoc tests (α = 5%).

RESULTS

Nanofibers with larger diameter were seen as CH concentration increased, while there was no effect on interfibrillar spaces. An increase in cell viability was seen for 0.4% CH, in all periods. Incorporation of CH and FN into the scaffolds increased cellular migration, spread, and viability, all intensified when CH and FN were combined. ALPL and DSPP expression, and ALP activity were not affected by CH and FN. COL1A1 was downregulated in all groups, while DMP1 was upregulated in the presence of CH, with no differences for the groups loaded with FN. CH increased the formation of mineralized matrix, which was not influenced by FN.

CONCLUSIONS

In conclusion, the incorporation of CH enhanced the odontogenic potential of HDPCs, irrespective of the presence of FN. The PCL + 0.4% CH formulation may be a useful strategy for use in dentin tissue engineering.

CLINICAL RELEVANCE

A change in the form of presentation of calcium hydroxide-based materials used for direct pulp capping can increase biocompatibility and prolong the vitality of dental pulp.

Chitosan-based nanocomposites: preparation and characterization for food packing industry

In the present work, Cerium (IV)-Zirconium (IV) oxide nanoparticles (CeO4ZrNPs) was successfully dispersed into Chitosan/15Gelatin nanocomposites with different quantities. The obtained chitosan-based nanocomposites represented remarkable improvements in structural, morphological, mechanical, and thermal properties. Roughness increased from 74 nm to 6.4 nm, Young’s Modulus enhanced from 1.36 GPa to 2.99 GPa. The influence of dispersed CeO4ZrNPs contents on the phase transition temperature (T g) and the non-isothermal degradation processes of chitosan-based nanocomposites were examined using Differential Scanning Galorimetry (DSC) with different heating rates. Kinetic parameters of the thermal degradation for chitosan-based nanocomposites were evaluated using Kissinger-Akahira-Sunose (KAS) and Kissenger (KIS) procedures. Chitosan-based nanocomposites showed an increase in the thermal degradation temperature with higher activation energies, indicating improved thermal stability. Thermal analysis demonstrated that chitosan-based nanocomposites became more ordered by increasing CeO4ZrNPs as inferred from the negative entropy increase. Moreover, the degradation of chitosan-based nanocomposites has been described as a non-spontaneous process. The resulting information is particularly important in applications in which there is a need to obtain chitosan nanocomposites with improved mechanical and thermal properties such as food packing industry.

Hydroxyethyl Chitosan-Reinforced Polyvinyl Alcohol/Biphasic Calcium Phosphate Hydrogels for Bone Regeneration

Fabrication of reinforced scaffolds for bone regeneration remains a significant challenge. The weak mechanical properties of the chitosan (CS)-based composite scaffold hindered its further application in clinic. Here, to obtain hydroxyethyl CS (HECS), some hydrogen bonds of CS were replaced by hydroxyethyl groups. Then, HECS-reinforced polyvinyl alcohol (PVA)/biphasic calcium phosphate (BCP) nanoparticle hydrogel was fabricated via cycled freeze-thawing followed by an in vitro biomineralization treatment using a cell culture medium. The synthesized hydrogel had an interconnected porous structure with a uniform pore distribution. Compared to the CS/PVA/BCP hydrogel, the HECS/PVA/BCP hydrogels showed a thicker pore wall and had a compressive strength of up to 5-7 MPa. The biomineralized hydrogel possessed a better compressive strength and cytocompatibility compared to the untreated hydrogel, confirmed by CCK-8 analysis and fluorescence images. The modification of CS with hydroxyethyl groups and in vitro biomineralization were sufficient to improve the mechanical properties of the scaffold, and the HECS-reinforced PVA/BCP hydrogel was promising for bone tissue engineering applications.

Enhancement of the mechanical properties of chitosan

Chitosan (CS) has been investigated for copious applications in the biomedical, industrial and environmental fields owing to its diverse advantageous traits. Nevertheless, CS exhibits debilitated mechanical stability. This debilitated mechanical stability constitutes an obstacle to nearly all of CS's applications. Hence, in this review we discussed different approaches that could be adopted in order to escalate the mechanical properties of CS. Chemical cross-linking was among these approaches where CS was chemically cross-linked with various agents, such as glutaraldehyde, vanillin, and genipin. Different plasticizers were also incorporated with CS. Moreover, nano-materials were added to CS so as to form nano-composites of enhanced mechanical properties. Porogens were also employed to increase the surface area available for the CS's physical and chemical cross-linking processes. Other reports attempted to modify the fabrication conditions and gelling system of CS as a means of producing mechanically stable CS gels.

Chitosan based nanofibers in bone tissue engineering

Bone tissue engineering involves biomaterials, cells and regulatory factors to make biosynthetic bone grafts with efficient mineralization for regeneration of fractured or damaged bones. Out of all the techniques available for scaffold preparation, electrospinning is given priority as it can fabricate nanostructures. Also, electrospun nanofibers possess unique properties such as the high surface area to volume ratio, porosity, stability, permeability and morphological similarity to that of extra cellular matrix. Chitosan (CS) has a significant edge over other materials and as a graft material, CS can be used alone or in combination with other materials in the form of nanofibers to provide the structural and biochemical cues for acceleration of bone regeneration. Hence, this review was aimed to provide a detailed study available on CS and its composites prepared as nanofibers, and their associated properties found suitable for bone tissue engineering.

Fabrication of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) biocomposites with reinforcement by hydroxyapatite using extrusion processing

The aim of this study was to prepare poly(3-hydroxybutyrate-co-3-hydroxyvalerate), PHBV, biocomposites with incorporating various percentages of hydroxyapatite (HAP) using extrusion processing. The biocomposites were produced by melt extrusion of PHBV with untreated HAP and surface-treated HAP crystals. The structure of biopolymer/HAP biocomposites was investigated by XRD, FTIR, DSC and SEM. Silane coupling agent was used for HAP surface treatment in PHBV/HAP composites. Silane-treated HAP nanoparticles yielded nanocomposites characterized by good mechanical performance and fine nanofiller dispersion, as shown by SEM investigations. The Halpin-Tsai and Hui-Shia models were used to evaluate the effect of reinforcement by HAP particles on the elastic modulus of the composites. Micromechanical models for initial composite stiffness showed good correlation with experimental values. Disparities in the Halpin-Tsai model were evident for composite with higher HAP loadings.

Emerging trends in eco-compliant, synergistic, and hybrid assembling of multifunctional polymeric bionanocomposites

The quest to develop eco-benign polymeric hybrid materials arose out of the need to protect the environment from the harmful effects of synthetic petroleum polymeric waste and meet the specific needs of industries such as oil and gas, aerospace, automotives, packaging, electronics biomedicals, pharmaceuticals, agricultural, and construction. This has resulted in synergistic hybrid assembling of natural fibers, polymers, biopolymers, and nanoparticles. Bionanocomposites based on inorganic nanoparticle reinforced biofiber, polymers and biopolymers, and polysaccharides such as chitosan, alginate, and cellulose derivatives, and so on, exhibiting at least a dimension at the nanometer scale, are an emerging group of nanostructured hybrid materials. These hybrid bionanocomposites exhibit structural and multifunctional properties suitable for versatile applications similar to polymer nanocomposites. Their biocompatibility and biodegradability provide opportunities for applications as eco-benign green nanocomposites. This review presents state-of-the-art progress in synergistic nanotechnological assembling of bionanocomposites relative to processing technologies, product development, and applications.

Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications

The state-of-the-art on calcium orthophosphate (CaPO4)-containing biocomposites and hybrid biomaterials suitable for biomedical applications is presented. Since these types of biomaterials offer many significant and exciting possibilities for hard tissue regeneration, this subject belongs to a rapidly expanding area of biomedical research. Through the successful combinations of the desired properties of matrix materials with those of fillers (in such systems, CaPO4 might play either role), innovative bone graft biomaterials can be designed. Various types of CaPO4-based biocomposites and hybrid biomaterials those are either already in use or being investigated for biomedical applications are extensively discussed. Many different formulations in terms of the material constituents, fabrication technologies, structural and bioactive properties, as well as both in vitro and in vivo characteristics have been already proposed. Among the others, the nano-structurally controlled biocomposites, those containing nanodimensional compounds, biomimetically fabricated formulations with collagen, chitin and/or gelatin, as well as various functionally graded structures seem to be the most promising candidates for clinical applications. The specific advantages of using CaPO4-based biocomposites and hybrid biomaterials in the selected applications are highlighted. As the way from a laboratory to a hospital is a long one and the prospective biomedical candidates have to meet many different necessities, the critical issues and scientific challenges that require further research and development are also examined.